QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-maintains-buy-on-orthopediatrics-lowers-price-target-to-26

Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $42 to $26.

 btig-reiterates-buy-on-orthopediatrics-maintains-23-price-target

BTIG analyst Ryan Zimmerman reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $23 price target.

 orthopediatrics-affirms-fy2025-sales-guidance-of-233500m-234500m-vs-235476m-est

OrthoPediatrics (NASDAQ:KIDS) affirms FY2025 sales outlook from $233.500 million-$234.500 million to $233.500 million-$234.500 ...

 orthopediatrics-q3-adj-eps-024-beats-026-estimate-sales-61250m-miss-62410m-estimate

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.2...

 orthopediatrics-gets-fdas-approval-for-3p-pediatric-plating-platform-small-mini-system

OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS), a company focused exclusively on adv...

 lake-street-maintains-buy-on-orthopediatrics-lowers-price-target-to-34

Lake Street analyst Ben Haynor maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $37 to $34.

 stifel-maintains-buy-on-orthopediatrics-lowers-price-target-to-20

Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $32 to $20.

 jmp-securities-maintains-market-outperform-on-orthopediatrics-lowers-price-target-to-25

JMP Securities analyst David Turkaly maintains OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and lowers the price t...

 piper-sandler-maintains-overweight-on-orthopediatrics-lowers-price-target-to-22

Piper Sandler analyst Matt O'Brien maintains OrthoPediatrics (NASDAQ:KIDS) with a Overweight and lowers the price target...

 btig-maintains-buy-on-orthopediatrics-lowers-price-target-to-23

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $39 to $23.

 orthopediatrics-lowers-fy2025-sales-guidance-from-237000m-242000m-to-233500m-234500m-vs-239440m-est

OrthoPediatrics (NASDAQ:KIDS) lowers FY2025 sales outlook from $237.000 million-$242.000 million to $233.500 million-$234.500 m...

 orthopediatrics-sees-q3-sales-61200m-vs-63590m-est

OrthoPediatrics (NASDAQ:KIDS) sees Q3 sales of $61.200 million vs $63.590 million analyst estimate.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION